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Neurexins Are Functional a-Latrotoxin Receptors
CL1 does not (Krasnoperov et al., 1997). Since a-latro-Shuzo Sugita, Mikhail Khvochtev,
and Thomas C. SuÈ dhof* toxin can trigger synaptic exocytosis of at least some
neurotransmitters without Ca21 (Misler and Hurlbut,Center for Basic Neuroscience and
Department of Molecular Genetics 1979), the Ca21 independence of CL1 and Ca21 depen-
dence of neurexin 1a suggested that CL1 is the realHoward Hughes Medical Institute
The University of Texas receptor for a-latrotoxin and that neurexin 1a is not a
functional receptor (Lelianova et al., 1997). However, theSouthwestern Medical Center
Dallas, Texas 75235 Ca21 independence of a-latrotoxin action is controver-
sial, and the possible function of neurexins as a-latro-
toxin receptors has not been tested directly. Studies of
neurexin 1a knockout mice demonstrated that a-latro-Summary
toxin can still trigger glutamate release in the absence
of neurexin 1a, although its potency is reduced (Gepperta-Latrotoxin is a potent neurotoxin that triggers syn-
et al., 1998). These data suggested that neurexin 1aaptic exocytosis. Surprisingly, two distinct neuronal
has a function related to a-latrotoxin without revealingreceptors for a-latrotoxin have been described: CIRL/
whether or not it is a functional a-latrotoxin receptor.latrophilin 1 (CL1) and neurexin-1a. a-Latrotoxin is
Exocytosis from chromaffin cells or PC12 cells is stim-thought to trigger exocytosis by binding to CL1, while
ulated by relatively high concentrations of a-latrotoxinthe role of neurexin 1a is uncertain. Using PC12 cells,
(.0.1 nM) in a Ca21-dependent manner. Expression ofwe now demonstrate that neurexins indeed function
CL1 in chromaffin cells or PC12 cells produces a majoras a-latrotoxin receptors that are at least as potent
shift in the a-latrotoxin concentration dependence ofas CL1. Both a- and b-neurexins represent autono-
these cells (Bittner et al., 1998; Sugita et al., 1998). Cellsmous a-latrotoxin receptors that are regulated by al-
containing CL1 are stimulated by picomolar instead ofternative splicing. Similar to CL1, truncated neurexins
nanomolar concentrations of a-latrotoxin. This resultwithout intracellular sequences are fully active; there-
provided crucial evidence that CL1 is indeed a realfore, neurexins and CL1 recruit a-latrotoxin but are
a-latrotoxin receptor. We have now used this assay tonot themselves involved in exocytosis. Thus, a-latro-
test if neurexins act as functional a-latrotoxin receptors.toxin is unique among neurotoxins, because it utilizes
Our data demonstrate that multiple neurexins are a-latro-two unrelated receptors, probably to amplify recruit-
toxin receptors that are regulated by alternative splicing.ment of a-latrotoxin to active sites.
Direct comparisons show that neurexins are more po-
tent in this assay than CL1 and that they do not cooper-Introduction
ate with CL1 in triggering exocytosis.
a-Latrotoxin is a potent excitatory neurotoxin that stimu-
lates synaptic vesicle exocytosis and induces massive Results
neurotransmitter release (reviewed by Rosenthal and
Meldolesi, 1989). At the synapse, a-latrotoxin binds to Neurexin 1a Is a Functional a-Latrotoxin Receptor
receptors close to the active zone to initiate exocytosis. We used PC12 cells transfected with human growth
Two high-affinity binding proteins for a-latrotoxin have hormone (hGH) as a model system to study secretion.
been described; neurexin 1a belongs to a family of poly- PC12 cells and other neuroendocrine cells secrete
morphic proteins, the neurexins, which resemble cell transfected hGH when stimulated by KCl depolarization
surface receptors (Ushkaryov et al., 1992; Missler and or nanomolar concentrations of a-latrotoxin. KCl or
SuÈ dhof, 1998). CIRL/latrophilin 1 (CL1) is part of a family a-latrotoxin stimulate exocytosis in these neuroendo-
of G protein±linked receptors called CLs (Krasnoperov crine cells only in the presence of Ca21 (Meldolesi et al.,
et al., 1997; Lelianova et al., 1997; Sugita et al., 1998). 1983; Bittner et al., 1998; Sugita et al., 1998). Exocytosis
Neurexins are expressed only in neurons, whereas CLs is inhibited by tetanus toxin or by inhibition of phosphati-
are enriched in brain but are additionally synthesized in dylinositol 4-kinase with phenylarsine oxide (Sugita et
all tissues (Ullrich et al., 1995; Sugita et al., 1998). al., 1998). Thus, transfected PC12 cells provide a suit-
Neurexin 1a and CL1 bind a-latrotoxin with a similar able model system for studying Ca21-triggered exo-
nanomolar affinity that suggests a receptor function. cytosis.
However, the use of separate, unrelated cell surface Transfection of CL1 into PC12 cells or chromaffin cells
receptors for a neurotoxin is unprecedented. The exis- sensitizes the secretory response of these cells to a-latro-
tence of two high-affinity binding proteins for a-latro- toxin (Bittner et al., 1998; Sugita et al., 1998). However,
toxin raised the possibility that one of them is the ªrealº CL1 does not change the Ca21 dependence of secretion
receptor, and the other constitutes a nonfunctional and decreases the amount of secretion at high toxin
a-latrotoxin-binding protein. Neurexin 1a requires Ca21 concentrations (.1 nM) (Bittner et al., 1998; Sugita et al.,
for binding of a-latrotoxin (Davletov et al., 1995), whereas 1998). These results demonstrated that CL1 functions as
an a-latrotoxin receptor in PC12 cells and chromaffin
cells. To test if neurexins also act as a-latrotoxin recep-* To whom correspondence should be addressed (e-mail: tsudho@
mednet.swmed.edu). tors, we cotransfected PC12 cells with hGH and either
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more than a thousand times over control-transfected
cells (Figure 1A). Secretion triggered by a-latrotoxin
from neurexin-transfected PC12 cells was still Ca21-
dependent, and maximal secretion evoked by a-latro-
toxin was decreased at high toxin concentrations (.1
nM) (Figure 1A).
Multiple Neurexins Function as a-Latrotoxin
Receptors Regulated by Alternative Splicing
We next investigated the possibility that other neurexins
besides neurexin 1a function as a-latrotoxin receptors
and that their activity may be regulated by alternative
splicing. For this purpose, we transfected PC12 cells
with neurexins with or without inserts in splice site 4
(SS4). SS4 was chosen, because alternative splicing in
SS4 regulates binding of b-neurexins to neuroligins and
thereby controls cell adhesion between neurons bearing
b-neurexins and neuroligins (Ichtchenko et al., 1995;
Nguyen and SuÈ dhof, 1997). In the initial experiments
shown in Figure 1A, a form of neurexin 1a that carries
no insert in SS4 was analyzed (N1a-1SS42). When we
expressed neurexin 1a containing an insert in SS4
(N1a-12SS41), hGH secretion was still elicited by picomo-
lar concentrations of a-latrotoxin that were inactive in
control-transfected cells (Figure 1B). However, hGH se-
cretion was markedly decreased compared with cells
transfected with neurexin 1a lacking an insert in SS4,
suggesting that neurexin 1a containing an insert in SS4
is less potent as an a-latrotoxin receptor than neurexin
1a lacking an insert.
We then tested if b-neurexins could also function as
an a-latrotoxin receptor (Figure 1C). Transfection of neu-
rexin 1b or 2b without an insert in SS4 (N1b-1SS42 and
N2b-4SS42) sensitized PC12 cells to a-latrotoxin, similar
to transfection of neurexin 1a. The amount of secretion
Figure 1. Neurexins Function as a-Latrotoxin Receptors triggered by a-latrotoxin, however, was less than the
(A) Ca21-dependent secretion of hGH from PC12 cells transfected secretion from neurexin 1a±transfected cells. When we
with a neurexin 1a expression vector (N1a-1) or a control vector transfected b-neurexins containing an insert in SS4
(Control). Transfected PC12 cells were stimulated with the indicated
(N1b-3SS41 and N2b-3SS41), we observed no potentiationconcentrations of recombinant a-latrotoxin in the presence or ab-
of the a-latrotoxin response (Figure 1C). These resultssence of Ca21 for 10 min. hGH was measured in the medium and
show that both a- and b-neurexins serve as a-latrotoxinthe cells. hGH secretion is expressed as a percentage of total hGH
present. Points are from two independent experiments. receptors in PC12 cells in a manner regulated by alterna-
(B) Regulation of neurexin 1a-receptor function by alternative splic- tive splicing.
ing. PC12 cells transfected with neurexin 1a without (N1a-1SS42) or
with (N1a-12SS41) an insert at splice site 4 or with a control vector
(Control) were stimulated with low concentrations of a-latrotoxin as Mechanism of Action of Neurexin 1a
indicated. Data are from two independent experiments performed as an a-Latrotoxin Receptor
in duplicates. Note expanded a-latrotoxin concentration range com-
The response of neurexin-transfected PC12 cells to pi-pared with (A).
comolar a-latrotoxin, a concentration that is inactive(C) b-Neurexins function as a-latrotoxin receptors regulated by alter-
with control cells, shows that neurexins are functionalnative splicing. PC12 cells transfected with neurexin 1b or 2b, with
and without inserts in splice site 4 (N1b-1SS42, N1b-3SS41, N2b-4SS42, a-latrotoxin receptors. However, the overall secretory
and N2b-3SS41, respectively), and control PC12 cells were stimulated response of neurexin-transfected PC12 cells to a-latro-
with low concentrations of a-latrotoxin. Data are from five indepen- toxin was decreased under our assay conditions (Figure
dent experiments.
1A), suggesting that neurexins may directly interfere
with the secretory apparatus of PC12 cells. To test this,
we investigated the effect of transfected neurexins in
PC12 cells on hGH secretion triggered by a differentneurexin 1a or a control plasmid. We then measured
hGH secretion as a function of a-latrotoxin (Figure 1A). secretagog, KCl depolarization (Figure 2). We detected
no change in exocytosis by a- or b-neurexins, whichTransfection of neurexin 1a caused a major shift in the
a-latrotoxin response curve to lower a-latrotoxin con- therefore do not directly interfere with the secretory ap-
paratus.centrations, making the cells responsive to picomolar
toxin concentrations. At these concentrations, hGH re- Why then does the maximal a-latrotoxin response ap-
pear to be depressed in PC12 cells transfected withlease from neurexin-transfected cells was enhanced
Neurexins Function as a-Latrotoxin Receptors
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Figure 2. Transfection of Neurexins Does Not Depress the Secre-
tory Response of PC12 Cells to KCl Depolarization
Release of hGH by KCl depolarization was measured in PC12 cells
transfected with control plasmid or various neurexin expression
vectors. See Experimental Procedures for description of the differ-
ent neurexin constructs used in the transfections.
neurexins? a-Latrotoxin requires Ca21 for triggering exo-
cytosis in PC12 cells; varying the Ca21 concentration
presumably modulates the amount of exocytosis. To
examine this possibility, we investigated the effect of
neurexins on the Ca21-dependence of exocytosis trig-
gered by a-latrotoxin (Figure 3A). A bell-shaped Ca21
dependence of exocytosis was observed in PC12 cells
transfected with hGH alone, with maximal secretion at
0.8 mM Ca21 and a decline in the response at higher Ca21
Figure 3. Ca21 Regulation of Exocytosis in PC12 Cellsconcentrations. However, in PC12 cells that express
(A) Ca21 dependence of hGH secretion in PC12 cells transfectedneurexin 1a, a similar bell-shaped curve was observed
with a control plasmid (Control) or a neurexin 1a expression plasmidwith dramatically shifted Ca21 dependence (Figure 3A).
(N1a-1SS42). PC12 cells were stimulated with 1 nM a-latrotoxin for
The neurexin cells responded maximally to lower Ca21 10 min in medium containing the indicated Ca21 concentrations.
concentrations than control cells (0.1 versus 0.8 mM The no Ca21 condition contained 0.2 mM EGTA.
Ca21), while the total amount of secretion was the same (B) Concentration dependence of ionomycin-triggered hGH secre-
tion from PC12 cells. PC12 cells were stimulated in the presencein neurexin and control cells (Figure 3A). These data
of 2.2 mM or 0.0 mM Ca21 for 10 min with solutions containingshow that the total secretory response to a-latrotoxin
the indicated concentrations of ionomycin, and the amount of hGHis not changed in transfected PC12 cells but that the
released was measured as described above. Data are from a single
Ca21 concentration dependence is shifted to lower Ca21 representative experiment and were repeated with separate prepa-
concentrations. The apparent decrease in the overall rations of ionomycin.
a-latrotoxin response observed in Figure 1A is thus due
to the fact that the Ca21 concentrations used were sub-
optimal. results demonstrate that bell-shaped dose±response
One of the mechanisms by which a-latrotoxin could curves are general features for secretagogs in PC12
act to trigger exocytosis is that of a Ca21 ionophore. cells but that a-latrotoxin is much more effective than
This is suggested by the Ca21 dependence of its effect a true Ca21 ionophore, suggesting that a-latrotoxin acts
in PC12 cells, although it is difficult to understand in by a mechanism distinct from that of a simple Ca21
this case why neurexin transfection sensitized the Ca21 ionophore. Neurexins contain only a single transmem-
response. To determine if a-latrotoxin acts similar to a brane region with a cytoplasmic tail that binds to CASK,
Ca21 ionophore, we examined the concentration depen- a PDZ domain protein, which in turn forms a complex
dence of ionomycin, a Ca21 ionophore, in exocytosis with mint 1 and velis (Hata et al., 1996; Butz et al., 1998).
(Figure 3B). Ionomycin induced Ca21-dependent secre- To probe if the cytoplasmic coupling of neurexins to
tion in transfected PC12 cells, again with a bell-shaped CASK or other proteins is essential for a-latrotoxin re-
dose±response curve. However, more than 5 mM iono- ceptor function, we investigated if truncated neurexin
mycin was required for exocytosis, whereas a-latrotoxin 1a is still active. We studied neurexin 1a that either
works at 103±106-fold lower concentrations. In addition, lacked the last three amino acids (which are essential
the maximal amount of exocytosis triggered by ionomycin for binding to CASK [Hata et al., 1996]) or the whole
was less than the maximum achieved with a-latrotoxin cytoplasmic tail (Figure 4). Transfections of both trun-
cated forms resulted in the same a-latrotoxin responsein the same cells (compare Figures 3A and 3B). These
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Figure 4. The Intracellular C-Terminal Tail of Neurexin 1a Is Not
Required for a-Latrotoxin Receptor Function
Full-length neurexin 1a (N1a-1) or truncated neurexin 1a lacking the
last three amino acids (N1a-1Stop1527) or the complete cytoplasmic
tail (N1a-1Stop1481) were cotransfected with hGH into PC12 cells. Re-
lease was stimulated by three concentrations of a-latrotoxin as
shown. Data are from three independent experiments performed in
duplicates.
as transfection of full-length neurexin. Recent studies
had shown that CL1, the other a-latrotoxin receptor that
is a G protein±linked receptor containing seven trans-
membrane regions, is also fully active when truncated
after the first transmembrane region (Sugita et al., 1998).
Thus, intracellular signal transduction by neurexins or
CL1 is not involved in the mechanism by which a-latro-
toxin triggers exocytosis.
a-Latrotoxin Receptor Function Correlates
with a-Latrotoxin Binding
The finding that neurexin 1b acts as an a-latrotoxin
receptor in PC12 cells (Figure 1) was unexpected, be-
cause in earlier studies, we had observed no binding of
a-latrotoxin to neurexin 1b (Davletov et al., 1995). The
major difference between the previous binding experi-
ments and the current PC12 cell experiments is the NaCl
Figure 5. Binding of 125I-Labeled a-Latrotoxin to Immobilized Neu-concentration used. The original binding experiments
rexin±IgG Fusion Proteins: Effects of Alternative Splicing, NaCl, andwere performed in 1 M NaCl in order to decrease non-
Ca21specific ionic interactions, whereas the PC12 cell experi-
Binding reactions were performed with IgG fusion proteins con-ments were performed at physiological salt concentra-
taining these extracellular sequences: neurexin 1a without (N1a-tions. To determine if binding of a-latrotoxin to neurexins
1SS42, [A]) or with (N1a-12SS41, [B]) an insert in splice site 4; neurexins
mirrors their a-latrotoxin receptor activity, we analyzed 1b, 2b, and 3b without an insert in splice site 4 (N1b-1SS42, N2b-
binding of 125I-labeled a-latrotoxin to immobilized IgG 4SS42, and N3b-1SS42 in [C], [E], and [G], respectively); neurexins 1b
and 2b with an insert in splice site 4 (N1b-3SS41 and N2b-3SS41 in [D]fusion proteins of various neurexins at different concen-
and [F], respectively); and control protein containing only IgG fusedtrations of NaCl with or without Ca21 (Figure 5).
to a signal sequence (H). Equal amounts of IgG proteins (≈2 mg)We first explored the effect of alternative splicing on
were immobilized on protein A-Sepharose and incubated with 125I-
a-latrotoxin binding to neurexin 1a. Neurexin 1a±IgG
labeled 0.1 nM a-latrotoxin (12,000 cpm total) before washing in
fusion protein without an insert in SS4 (N1a-1SS42) bound buffered NaCl solutions with the indicated NaCl concentration. Ex-
a-latrotoxin in a Ca21-dependent manner (Figure 5A). periments were carried out in the presence and absence of Ca21
to control for nonspecific binding. Panels show a representativea-Latrotoxin was stably bound at salt concentrations of
experiment repeated multiple times.up to 1.5 M NaCl; no binding was observed with control
IgG protein (Figure 5H). Neurexin 1a containing an insert
in SS4 (N1a-12SS41) bound a-latrotoxin only weakly at
low-NaCl concentrations and not at all at high NaCl C-terminal regions of the extracellular domains. In
agreement with this hypothesis, we observed no bindingconcentrations (Figure 5B). These results suggest that
alternative splicing in SS4 regulates a-latrotoxin binding of a-latrotoxin to neurexin 1a lacking the C-terminal
parts of the extracellular domains (data not shown).and that the binding site for a-latrotoxin includes the
Neurexins Function as a-Latrotoxin Receptors
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Figure 7. Neurexin 1a and CL1 Are Independent, Autonomously
Acting a-Latrotoxin Receptors
PC12 cells were transfected individually with neurexin 1a, neurexin
1b, CL1, or control DNA or cotransfected with neurexin 1a and CL1
as indicated. hGH release triggered by various concentrations of
a-latrotoxin was measured. Data shown are from three independent
Figure 6. Effect of the Amount of Transfected DNA on the a-Latro- experiments.
toxin Response in PC12 Cells
PC12 cells were cotransfected with an hGH plasmid and the indi-
cated amounts of a control plasmid or plasmids encoding CL1, the question of whether transfected neurexins and CL1
neurexin 1a, or neurexin 1b. Transfected cells were stimulated for act cooperatively in exocytosis by collaborating with
10 min with 0.03 nM a-latrotoxin, and the percentage of hGH re- endogenous CL1 and neurexins, respectively.
leased was measured. Data shown are from two independent experi-
To address this possibility, we first measured the rela-ments.
tive effectiveness of neurexins and CL1 as a-latrotoxin
receptors. Since it is impossible to standardize expres-
sion levels in these transfection experiments becauseWe then characterized the a-latrotoxin-binding prop-
erties of b-neurexins. b-Neurexins are essentially com- of the low efficiency of the transfections, we investigated
if the level of expression achieved in the transfectionsposed of the C-terminal parts of a-neurexins. The
b-neurexin sequence includes SS4, which is also alter- was saturating. This was studied by systematic in-
creases in the amount of transfected plasmid DNA fornatively spliced in b-neurexins (Ullrich et al., 1995). At
low-NaCl concentrations, all three b-neurexins without each receptor (Figure 6). Over a 10-fold concentration
range, the effects of the transfections were very similaran insert in SS4 (N1b-1SS42, N2b-4SS42, and N3b-1SS42)
bound a-latrotoxin almost as well as neurexin 1a (Fig- for all plasmids. On average, neurexin 1a produced a
significantly higher activation of exocytosis than CL1ures 5C, 5E, and 5G). a-Latrotoxin binding was Ca21-
dependent but was very sensitive to the NaCl concentra- or neurexin 1b, independent of how much DNA was
transfected (Figure 6). These results indicate that as antion, with virtually no binding at 0.5 M NaCl or more.
Similar to the situation with neurexin 1a, binding of a-latrotoxin receptor, neurexin 1a is at least as effective
as CL1.a-latrotoxin to b-neurexins was regulated by alternative
splicing. Neurexins 1b and 2b containing an insert in We next investigated the possibility that transfected
neurexins cooperate with endogenous CL1, or trans-SS4 (N1b-3SS41 and N2b-3SS41) were unable to bind
a-latrotoxin even at very low concentrations of NaCl fected CL1 with endogenous neurexins, in promoting
exocytosis. To address this possibility, we compared(Figures 5D and 5F). These data establish that all neurex-
ins are Ca21-dependent a-latrotoxin receptors with a PC12 cells cotransfected with CL1 and neurexin 1a with
PC12 cells that were individually transfected with eitherfunction regulated by alternative splicing in SS4, which
therefore must be part of the binding site. CL1 or neurexin 1a (Figure 7). Cotransfection of both
receptors did not enhance secretion stimulated by
a-latrotoxin but slightly attenuated it. Especially at low-Do Neurexins and CL1 Function Independently
or Cooperatively as a-Latrotoxin Receptors? toxin concentrations (30 pM a-latrotoxin), neurexin 1a±
transfected cells behaved significantly better than CL1-PC12 cells that do not express neurexins or CL1 still
respond to a-latrotoxin, although much higher toxin con- transfected cells or cells cotransfected with CL1 and
neurexin 1a. Thus, there is no added benefit from thecentrations are needed. This indicates that endogenous
receptors must be present. PCR and immunoblotting simultaneous presence of both receptor types.
experiments revealed that the PC12 cells we are using
(obtained from ATCC) express low levels of endogenous Discussion
CL1 and various neurexins (data not shown). As de-
scribed above, CL1 and neurexins are similar in that both a-Latrotoxin is a potent neurotoxin with unusual proper-
ties. With a size of 120 kDa, a-Latrotoxin is one of themake PC12 cells capable of responding to picomolar
instead of nanomolar concentrations of a-latrotoxin (see largest known neurotoxins. a-Latrotoxin contains 21 an-
kyrin repeats (Kiyatkin et al., 1990), more than any otherFigure 1 and Sugita et al., 1998). This observation poses
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protein except for ankyrin; no other known extracellular binding of a-latrotoxin to its two receptors also does
protein has ankyrin repeats. Functionally, a-latrotoxin not directly activate a receptor-based exocytotic signal.
probably stimulates the vesicular release apparatus di- The most plausible model to explain these data is that
rectly, whereas most neurotoxins modulate channels or the two receptors for a-latrotoxin function indepen-
neurotransmitter receptors. The current study identifies dently to recruit a-latrotoxin to the cell membrane of
another unusual property of a-latrotoxin: a-latrotoxin PC12 cells or nerve terminals, where a-latrotoxin then
acts via two independent families of receptors that are acts by an as yet unknown downstream mechanism.
both fully functional but structurally unrelated. These Why are there two independent, autonomously acting
receptors are neurexins and CL1. No other toxin utilizes a-latrotoxin receptors? Our results and previous studies
two distinct protein families as autonomously acting suggest that the density of a-latrotoxin receptors is lim-
receptors. iting in determining the magnitude of the a-latrotoxin
Our data provide the first direct evidence that neurex- response in nerve terminals or neuroendocrine cells.
ins represent functional a-latrotoxin receptors. Since PC12 cells contain endogenous a-latrotoxin receptors,
a-latrotoxin binds to synapses and acts on synaptic but these are insufficient for a complete response to low
exocytosis (Valtorta et al., 1984; Matteoli et al., 1988), concentrations of a-latrotoxin (Figure 1A). As a result,
this finding links neurexins to synapses. Neurexins are transfection of more receptors, either as neurexins or
extensively modified by alternative splicing. We ob- CL1, dramatically increases the a-latrotoxin response
served that the most important determinant for the of the cells, implying that receptor density drives the
a-latrotoxin receptor function of neurexins was alterna- a-latrotoxin response. Similarly, in neurexin 1a knockout
tive splicing at SS4. At the same position, alternative mice, the a-latrotoxin response is decreased in the pres-
splicing of b-neurexins regulates binding of neuroligins ence of Ca21, even though the other neurexins and CL1
(Ichtchenko et al., 1995; Nguyen and SuÈ dhof, 1997). Neu- are still present (Geppert et al., 1998). This finding also
roligins are synaptic cell adhesion molecules that are suggests that the receptor density is limiting. In terms
highly enriched in postsynaptic densities (Song et al., of evolution, it is possible that having two receptors
1999). Thus, both endogenous and exogenous ligands conferred an advantage onto a-latrotoxin, because the
for neurexins interact with the same alternatively spliced presence of two instead of one receptor increased the
sequence of neurexins, and both target the synapse. certainty of a response in all nerve terminals. According
Our finding that b-neurexins also serve as functional to this model, the two independent receptors for a-latro-
a-latrotoxin receptors, similar to neurexin 1a, was sur- toxin ensure that binding causes a maximal effect. The
prising, because previous experiments had identified difference between synaptic nerve terminals and neuro-
only neurexin 1a as an a-latrotoxin-binding protein (Dav- endocrine cells would be due to the differences in down-
letov et al., 1995). This discrepancy can be explained stream targets. It is plausible that synapses, with their
by the high-salt buffers that were used in the earlier highly specialized apparatus for maintaining predocked
experiments to increase binding specificity. As shown vesicles, contain proteins that mediate the Ca21-inde-
here, concentrations of more than 0.5 M NaCl inhibit pendent actions of a-latrotoxin and are not expressed
a-latrotoxin binding to b-neurexins (Figure 5). The same in neuroendocrine cells. Testing this model will depend
b-neurexins bind a-latrotoxin at lower NaCl concentra- on identification of these downstream targets.
tions and are functional as a-latrotoxin receptors when
analyzed in physiological buffers (Figure 1).
Experimental ProceduresWhat are the implications of having two distinct recep-
tors for the mechanism of action of a-latrotoxin? Neurex- Construction of Expression Vectors
ins are type I membrane proteins likely to function as cell and Transfection Experiments
adhesion molecules (reviewed by Missler and SuÈ dhof, Constructs Encoding IgG Fusion Proteins
Most pCMVIG constructs were described previously (Ushkaryov et1998), whereas CL1 is a G protein±coupled receptor with
al., 1994; Davletov et al., 1995) and contain the following extracellularseven transmembrane regions (Krasnoperov et al., 1997;
sequences of various neurexins fused to human IgG: pCMVIGL-CLelianova et al., 1997). a-Latrotoxin is thought to stimu-
(control IgG), residues 1±18 of rat neurexin 1a; pCMVIGbN1a-1 (N1a-late the secretory apparatus directly (Rosenthal and 1), residues 1±1361 of bovine neurexin 1a lacking an insert in SS4;
Meldolesi, 1989), which could potentially be carried out pCMVIGN1b-1 (N1b-1) and pCMVIGN1b-3 (N1b-3), residues 1±299
by the intracellular sequences of its receptors. How- of rat neurexin 1b without (N1b-1) or with (N1b-3) an insert in SS4;
ever, neurexins and CL1 share no similarity and trans- pCMVIGN2b-3 (N2b-3) and pCMVIGN2b-4 (N2b-4), residues 1±392
of rat neurexin 2b with (N2b-3) or without (N2b-4) an insert in SS4;duce no obvious common intracellular signals, making
and pCMVIGN3b-1 (N3b-1), residues 1±378 of bovine neurexin 3bit unlikely that they both directly activate exocytosis. In
without an insert in SS4. pCMVIGbN1a-12 (N1a-12) was constructedsupport of this hypothesis, we had previously shown
by replacing a 3.6 kb BssHII±SalI fragment of pCMVIGbN1a-1 with
that the intracellular sequences of CL1 are completely a 3.6 kb BssHI±SalI fragment from pBBL36a, resulting in a fusion
dispensable in PC12 cells for triggering exocytosis, sug- of residues 1±1361 of bovine neurexin 1a with an insert at SS4 to
gesting that such activation could potentially be carried IgG. pCMVIGbN1a-14stop611 was made by cloning a 1.9 kb EcoRI±KpnI
out by neurexins (Sugita et al., 1998). We now show, fragment of pBB106a (Ullrich et al., 1995) into the same site of
pCMVIG9 and contains residues 1±611 of bovine neurexin 1a.however, that the intracellular tail of neurexin 1a is also
Constructs Encoding Membrane Proteinsunnecessary for stimulating exocytosis in PC12 cells.
pCMVbN1a-1 (N1a-1) was constructed by combining a 4.4 kbThis result demonstrates that neither receptor acts by
EcoRI±SalI fragment from pBBL106a with a 0.5 kb SalI±BglII frag-
intracellular signal transduction. A similar conclusion ment from pBBL106a at the EcoRI-BamHI site of pCMV5, result-
was reached in independent experiments with recombi- ing in full-length bovine neurexin 1a lacking an insert at SS4.
nant a-latrotoxins in presynaptic nerve terminals (Icht- pCMVbN1a-12 (N1a-12) was constructed by fusing a 4.2 kb EcoRI
fragment and a 0.3 kb EcoRI±SalI fragment of pCMVIGbN1a-12 withchenko et al., 1998). These experiments showed that
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a 0.5 kb SalI±BglII fragment from pBBL106a, resulting in full-length for all reactions, followed by 34 cycles of 30 s at 948C, 30 s at 628C
(for Neurexin 1a), 548C (for Neurexin 1b), or 608C (for CL1), and 1bovine neurexin 1a containing an insert at SS4. pCMVbN1a-1Stop1481
and pCMVbN1a-1Stop1527 were made by fusing a 4.4 kb EcoRI±SalI min at 688C. The primers used were the following: neurexin 1a, A 5
GACTTCCTTCAGTGGCCCGCT and B 5 CACATTTCCCACTATGGCfragment of pCMVbN1a-1 with a 0.3 kb SalI±XbaI PCR product or
a 0.4 kb SalI±XbaI PCR product, respectively, in the EcoRI-XbaI GATG (product sizes, 0.55 kb without SS4 and 0.65 kb with SS4);
neurexin 1b, C 5 GCAATCTACAGGTCACCAGCATC and B (productsites of pCMV5. pCMVN1b-1 (pCMVL13; neurexin 1b without an
insert in SS4) was constructed by cloning a 1.3 kb PCR fragment sizes, 0.6 kb without SS4 and 0.7 kb with SS4); and CL1, D 5
CGAGGCCGAAACCTAGCGGAT and E 5 CTGCCAGGTAGCCCTCA(digested with KpnI±XhoI) on p622±11 into the KpnI±SalI site of
pCB1. pCMVN1b-3 (neurexin 1b with an insert in SS4) was con- TGGCT (product size, 0.5 kb).
structed by fusing a 0.9 kb KpnI±SalI fragment of pCMVIGN1b-3
with a 0.5 kb SalI±BamHI fragment of pCMVL13 into the KpnI±BamHI
site of pCMV5. pCMVN2b-3 was constructed by fusing a 0.75 kb Acknowledgments
EcoRI±KpnI fragment from pCMVIGN2b-3 with a 1.2 kb KpnI±XbaI
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contain full-length rat neurexin 2b either lacking (pCMVN2b-4) or MH50824 to T. C. S.
containing (pCMVN2b-3) an insert at SS4. The hGH expression vec-
tor was described previously (Sugita et al., 1998). Expression of all
constructs was verified in transfected COS cells. IgG fusion proteins Received November 10, 1998; revised January 11, 1999.
were produced in transfected COS cells and purified from the me-
dium on protein A-Sepharose beads as described (Ushkaryov et al.,
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